All CAR-T cells articles
-
NewsEngineered bacteria paint targets on tumors for cancer-killing T cells to see
Columbia engineers are the first to program bacteria to act as beacons that guide the activity of engineered T cells. This work is also the first to design interactions between these two “living” medicines to enable targeting of a range of solid tumor.
